AWARD A LETTER CONTRACT FOR RADX TECH - OASIS DIAGNOSTICS TO COMPLETE THE VALIDATION, APPROVAL, AND PRODUCTION PROCESSES IN ORDER TO SCALE UP CAPACITY

Oasis Diagnostics提供了一系列用于标准化唾液采集的创新工具，包括专用于无细胞RNA /病毒RNA的设备，非常适合对困难的唾液标本进行COVID-19检测。特别是这些采集工具[PureSAL、SuperSAL、MicroSAL和SimplOFy]与所使用的检测无关，并且已经被许多开发基于口腔/唾液的COVID-19检测的公司所使用。Oasis是一家员工不到20人的小企业，开发COVID-19的公司要求扩大制造规模，以便每天生产超过100，000单位的这些技术。 为了能够实现这一目标，Oasis Diagnostics需要额外的人力、设备和资源，而这些都是它目前所不具备的。 因此，Oasis正在通过RADx计划寻求资金，以促进大规模生产，以满足快速增长的唾液收集技术市场

Oasis Diagnostics provides a series of innovative tools for standardized saliva acquisition including devices specific for cell free RNA / viral RNA that are ideally suited for COVID-19 testing on difficult saliva specimens. These collection tools [Pure•SAL, Super•SALâ„¢, Micro•SAL and SimplOFy] in particular are agnostic to the test being used and are already being used by many companies developing oral / saliva based tests for COVID-19. Oasis is a small business with under 20 employees and has been requested by companies developing COVID-19 to scale up manufacturing in order to produce volumes in excess of 100,000 Units of these technologies on a daily basis.  In order to be able to meet this goal, Oasis Diagnostics requires additional manpower, equipment and additional resources that it does not have at the present time.  As a result Oasis is seeking funding through the RADx Program to facilitate large scale manufacturing to meet the rapidly growing market for saliva collection technologies